Point-of-Care (POC) Testing

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

Explore the comprehensive analysis of the POC testing market, its growth prospects, and the key players driving innovation in this essential segment of the healthcare industry in Kalorama Information’s report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition.

By the middle of the decade, the global point-of-care (POC) testing market is expected to…

Kalorama Information’s latest report, The Market and Potential for Molecular Point of Care (mPOC), 2021, provides comprehensive market sizing, forecasting, trend mapping, and competitive analysis for point of care (POC) tests using PCR or other molecular technologies. Designed for near-patient settings, these tests offer fast turnaround times. Major in vitro diagnostic (IVD) companies such as…

Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides…

Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2^nd Edition,…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…

Sexually transmitted diseases (STDs) present a significant public health challenge, with approximately 550 million new cases worldwide each year, including over 35 million in the US alone. Kalorama Information’s latest report, Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics), offers an in-depth analysis of the global market for STD testing services and diagnostics from…